Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 2 Trials

Maryland

Phase 2 colorectal cancer trials in Maryland

11 Phase 2 colorectal cancer studies are recruiting participants at sites in 3 cities across Maryland as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 467-9061
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse Maryland by city

Cities with the most studies recruiting right now.

Every Maryland city with a recruiting study

Baltimore (7), Bethesda (3), Columbia (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Maryland

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

    • Phase 2
    • Ages 18 to 72
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Bethesda
    Registry record
    NCT01174121 · updated
  2. Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Solstice Oncology, Inc.
    Recruiting in
    Baltimore
    Registry record
    NCT07808151 · updated
  3. Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Dustin Deming
    Recruiting in
    Baltimore
    Registry record
    NCT06493019 · updated
  4. E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Christian Hinrichs
    Recruiting in
    Bethesda
    Registry record
    NCT05686226 · updated
  5. PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

    • Phase 2
    • Ages 18 to 120
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Bethesda
    Registry record
    NCT05286814 · updated
  6. A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Baltimore
    Registry record
    NCT07023289 · updated
  7. A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    NSABP Foundation Inc
    Recruiting in
    Baltimore
    Registry record
    NCT07058012 · updated
  8. Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Recruiting in
    Baltimore
    Registry record
    NCT07281768 · updated
  9. A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    SCRI Development Innovations, LLC
    Recruiting in
    Columbia
    Registry record
    NCT07011576 · updated
  10. Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Recruiting in
    Baltimore
    Registry record
    NCT06205836 · updated
  11. An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    NGM Biopharmaceuticals, Inc
    Recruiting in
    Baltimore
    Registry record
    NCT07033026 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Maryland on ClinicalTrials.gov.

Ask about studies in Maryland

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.

Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 467-9061

or send a short form

How should we reach you?

Call